Improving cervical cancer control for women in low- and middle-income countries
Official title: The Empilisweni Center for Women's Health - Advancing Implementation of Equitable Cervical Cancer Control
Funded at Columbia University Health Sciences · NIH-10931463 · Data updated 2026-11-12
This study is working to improve cervical cancer prevention and treatment in low- and middle-income countries by promoting a simple approach that uses HPV testing and immediate care for early signs of cancer, making sure everyone can access these important services.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $1,068,363 |
| NIH project number | 5U54CA284030-02 |
| Project ID | NIH-10931463 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women living in low- and middle-income countries who are at risk for cervical cancer.
✕Less likely to help
Patients living in high-income countries or those who have already received comprehensive cervical cancer screening and treatment may not benefit from this research.
What this research studies
This research focuses on enhancing the implementation of effective cervical cancer control strategies, particularly in low- and middle-income countries. It aims to promote the use of HPV-based screening and immediate treatment of pre-cancerous lesions, known as the screen-and-treat approach. The project involves collaboration between Columbia University and the University of Cape Town, leveraging decades of experience to address barriers to implementation, such as costs and financing. By working closely with healthcare providers and communities, the research seeks to ensure equitable access to cervical cancer prevention and treatment.
Why it matters
Potential benefit: If successful, this research could significantly reduce cervical cancer rates and improve health outcomes for women in underserved populations.
How similar studies have gone: Previous research has demonstrated the effectiveness of HPV-based screening and treatment, indicating that this approach has the potential for success in similar contexts.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: Castor, Delivette — Columbia University Health Sciences
- Study coordinator: Castor, Delivette
Related research
Other NIH-funded projects on the same topics.
-
Community and digital tools to reduce HPV and cervical cancer burden
A nurse or health team will test a community-based, digital strategy to help girls and young women, especially in rural areas, get HPV vaccination and cervical cancer prevention services.
-
Community and digital tools to reduce HPV and cervical cancer in women with HIV
A community- and digital-technology program aims to help girls and young women, including those with HIV, get more HPV vaccination and cervical cancer prevention services.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
Hybrid approach to boost cervical cancer screening in Uganda
A tested, community-driven program helps Ugandan women encourage their peers to get free VIA cervical cancer screening.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.